Immunology

Top Story

IAS 2018: Advances, collaboration in immune-mediated inflammatory diseases

IAS 2018: Advances, collaboration in immune-mediated inflammatory diseases
April 26, 2018
FDA News

FDA declines proposed Rituxan, Herceptin biosimilars from Celltrion

April 6, 2018
The FDA has rejected approval of Celltrion’s biologics license applications for Truxima, a proposed rituximab biosimilar, and Herzuma, a proposed trastuzumab…
In the Journals

Stem cell transplant improves overall, event-free survival in scleroderma

January 3, 2018
Myeloablative autologous stem cell transplantation improved long-term clinical outcomes, including overall survival and event-free survival, among patients with diffuse…
In the Journals

Pneumocystis prophylaxis may be unnecessary in autoimmune blistering diseases

September 11, 2017
One patient in a large cohort of individuals with autoimmune blistering diseases developed pneumocystis pneumonia, suggesting that routine prophylaxis of this condition…
More Headlines »
Healio Jobs